Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-10

Clinical Trial Update: A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)

View source ↗

Summary

An observational study (NCT00705289) assessing characteristics of rheumatoid arthritis in patients treated with infliximab; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2010-06-10